Literature DB >> 26115971

Subsequent mortality after hyperglycemic crisis episode in the non-elderly: a national population-based cohort study.

Yuan Kao1, Chien-Chin Hsu1,2, Shih-Feng Weng3, Hung-Jung Lin1,2,4, Jhi-Joung Wang3, Shih-Bin Su5,6, Chien-Cheng Huang7,8,9,10,11, How-Ran Guo12,13.   

Abstract

Hyperglycemic crisis episodes (HCEs)-diabetic ketoacidosis and the hyperosmolar hyperglycemic state-are the most serious acute metabolic complications of diabetes. We aimed to investigate the subsequent mortality after HCE in the non-elderly diabetic which is still unclear. This retrospective national population-based cohort study reviewed, in Taiwan's National Health Insurance Research Database, data from 23,079 non-elder patients (≤65 years) with new-onset diabetes between 2000 and 2002: 7693 patients with HCE and 15,386 patients without HCE (1:2). Both groups were compared, and follow-up prognoses were done until 2011. One thousand eighty-five (14.1%) patients with HCE and 725 (4.71%) patients without HCE died (P < 0.0001) during follow-up. Incidence rate ratios (IRR) of mortality were 3.24 times higher in patients with HCE than in patients without HCE (P < 0.0001). Individual analysis of diabetic ketoacidosis and hyperosmolar hyperglycemic state also showed the similar result with combination of both. After stratification by age, mortality was significant higher in the middle age (40-64 years) [IRR 3.29; 95% confidence interval (CI) 2.98-3.64] and young adult (18-39 years) (IRR 3.91; 95% CI 3.28-4.66), but not in the pediatric subgroup (<18 years) (IRR 1.28; 95% CI 0.21-7.64). The mortality risk was highest in the first month (IRR 54.43; 95% CI 27.98-105.89), and still high after 8 years (IRR 2.05; 95% CI 1.55-2.71). After adjusting for age, gender, and selected comorbidities, the mortality hazard ratio for patients with HCE was still four times higher than for patients without HCE. Moreover, older age, male gender, stroke, cancer, chronic obstructive pulmonary disease, congestive heart failure, and liver disease were independent mortality predictors. HCE significantly increases the subsequent mortality risk in the non-elderly with diabetes. Strategies for prevention and control of comorbidities are needed as soon as possible.

Entities:  

Keywords:  Diabetes; Hyperglycemic crisis; Middle age; Mortality; Non-elderly; Pediatric; Young adult

Mesh:

Year:  2015        PMID: 26115971     DOI: 10.1007/s12020-015-0669-8

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  28 in total

1.  Burden of hospitalizations primarily due to uncontrolled diabetes: implications of inadequate primary health care in the United States.

Authors:  Sunny Kim
Journal:  Diabetes Care       Date:  2007-02-08       Impact factor: 19.112

2.  Long-term Mortality Risk After Hyperglycemic Crisis Episodes in Geriatric Patients With Diabetes: A National Population-Based Cohort Study.

Authors:  Chien-Cheng Huang; Shih-Feng Weng; Kang-Ting Tsai; Ping-Jen Chen; Hung-Jung Lin; Jhi-Joung Wang; Shih-Bin Su; Willy Chou; How-Ran Guo; Chien-Chin Hsu
Journal:  Diabetes Care       Date:  2015-02-09       Impact factor: 19.112

3.  All-cause and cardiovascular mortality risk in U.S. adults with and without type 2 diabetes: Influence of physical activity, pharmacological treatment and glycemic control.

Authors:  Ruth E Brown; Michael C Riddell; Alison K Macpherson; Karissa L Canning; Jennifer L Kuk
Journal:  J Diabetes Complications       Date:  2013-07-23       Impact factor: 2.852

4.  Predictors of hyperglycaemic crises and their associated mortality in Jamaica.

Authors:  Stephanie T Chung; Gillian Gordon Perue; Ayesha Johnson; Novie Younger; Carla S Hoo; Rosemarie Wright Pascoe; Michael S Boyne
Journal:  Diabetes Res Clin Pract       Date:  2006-02-03       Impact factor: 5.602

Review 5.  Hyperglycemic crises in adult patients with diabetes.

Authors:  Abbas E Kitabchi; Guillermo E Umpierrez; John M Miles; Joseph N Fisher
Journal:  Diabetes Care       Date:  2009-07       Impact factor: 17.152

6.  Associations of measures of lung function with insulin resistance and Type 2 diabetes: findings from the British Women's Heart and Health Study.

Authors:  D A Lawlor; S Ebrahim; G Davey Smith
Journal:  Diabetologia       Date:  2003-12-24       Impact factor: 10.122

7.  A mortality prediction model in diabetic ketoacidosis.

Authors:  Stamatis P Efstathiou; Aphrodite G Tsiakou; Dimitrios I Tsioulos; Ioannis D Zacharos; Athanasios G Mitromaras; Stylianos E Mastorantonakis; Themistoklis N Panagiotou; Theodore D Mountokalakis
Journal:  Clin Endocrinol (Oxf)       Date:  2002-11       Impact factor: 3.478

8.  Nutritionist visits, diabetes classes, and hospitalization rates and charges: the Urban Diabetes Study.

Authors:  Jessica M Robbins; Gail E Thatcher; David A Webb; Vivian G Valdmanis
Journal:  Diabetes Care       Date:  2008-01-09       Impact factor: 19.112

9.  Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer.

Authors:  Samantha F Ehrlich; Charles P Quesenberry; Stephen K Van Den Eeden; Jun Shan; Assiamira Ferrara
Journal:  Diabetes Care       Date:  2009-10-06       Impact factor: 19.112

10.  Infection, absent tachycardia, cancer history, and severe coma are independent mortality predictors in geriatric patients with hyperglycemic crises.

Authors:  Chien-Cheng Huang; Tsair-Wei Chien; Shih-Bin Su; How-Ran Guo; Wei-Lung Chen; Jiann-Hwa Chen; Su-Hen Chang; Hung-Jung Lin; Yi-Fong Wang
Journal:  Diabetes Care       Date:  2013-09       Impact factor: 19.112

View more
  8 in total

1.  Diabetic ketosis during hyperglycemic crisis is associated with decreased all-cause mortality in patients with type 2 diabetes mellitus.

Authors:  Ivan Kruljac; Miroslav Ćaćić; Petra Ćaćić; Vedran Ostojić; Mario Štefanović; Aljoša Šikić; Milan Vrkljan
Journal:  Endocrine       Date:  2016-09-03       Impact factor: 3.633

2.  Association between hyperglycaemic crisis and long-term major adverse cardiovascular events: a nationwide population-based, propensity score-matched, cohort study.

Authors:  Li-Hsin Chang; Liang-Yu Lin; Ming-Tsun Tsai; Chorng-Kuang How; Jen-Huai Chiang; Vivian Chia-Rong Hsieh; Sung-Yuan Hu; Ming-Shun Hsieh
Journal:  BMJ Open       Date:  2016-08-23       Impact factor: 2.692

3.  Diagnostic Usefulness of Serum Albumin as a Predictor of Diabetic Ketoacidosis.

Authors:  Jayagowri Karthikeyan; Sujatha Rajaragupathy
Journal:  Indian J Crit Care Med       Date:  2018-10

4.  Sociodemographic, Clinical, and Treatment-Related Factors Associated With Hyperglycemic Crises Among Adults With Type 1 or Type 2 Diabetes in the US From 2014 to 2020.

Authors:  Rozalina G McCoy; Rodolfo J Galindo; Kavya Sindhu Swarna; Holly K Van Houten; Patrick J O'Connor; Guillermo E Umpierrez; Nilay D Shah
Journal:  JAMA Netw Open       Date:  2021-09-01

5.  Impact of acute hyperglycemic crisis episode on survival in individuals with diabetic foot ulcer using a machine learning approach.

Authors:  Liling Deng; Puguang Xie; Yan Chen; Shunli Rui; Cheng Yang; Bo Deng; Min Wang; David G Armstrong; Yu Ma; Wuquan Deng
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-25       Impact factor: 6.055

6.  Lifetime risk and health-care burden of diabetic ketoacidosis: A population-based study.

Authors:  Fahim Ebrahimi; Alexander Kutz; Emanuel Remigius Christ; Gabor Szinnai
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-24       Impact factor: 6.055

7.  Association between Serum Albumin Concentration and Ketosis Risk in Hospitalized Individuals with Type 2 Diabetes Mellitus.

Authors:  Po-Chung Cheng; Shang-Ren Hsu; Yun-Chung Cheng
Journal:  J Diabetes Res       Date:  2016-07-18       Impact factor: 4.011

8.  Activation of neutral sphingomyelinase 2 through hyperglycemia contributes to endothelial apoptosis via vesicle-bound intercellular transfer of ceramides.

Authors:  Andreas Zietzer; Alina Lisann Jahnel; Marko Bulic; Katharina Gutbrod; Philip Düsing; Mohammed Rabiul Hosen; Peter Dörmann; Nikos Werner; Georg Nickenig; Felix Jansen
Journal:  Cell Mol Life Sci       Date:  2021-12-24       Impact factor: 9.261

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.